Modern Vaccines/Adjuvants Formulation-Session 2 (Plenary II): May 15-17, 2013-Lausanne, Switzerland.

Détails

ID Serval
serval:BIB_5FA845110D5C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Modern Vaccines/Adjuvants Formulation-Session 2 (Plenary II): May 15-17, 2013-Lausanne, Switzerland.
Périodique
Human Vaccines and Immunotherapeutics
Auteur(s)
Collin N.
ISSN
2164-554X (Electronic)
Statut éditorial
Publié
Date de publication
2013
Volume
9
Numéro
9
Pages
2015-2016
Langue
anglais
Résumé
On the 15-17th May 2013, the Fourth International Conference on Modern Vaccines/Adjuvants Formulation was organized in Lausanne, Switzerland, and gathered stakeholders from academics and from the industry to discuss several challenges, advances and promises in the field of vaccine adjuvants. Plenary session 2 of the meeting was composed of four different presentations covering: (1) the recent set-up of an adjuvant technology transfer and training platform in Switzerland, (2) the proposition to revisit existing paradigms of modern vaccinology, (3) the properties of polyethyleneimine as potential new vaccine adjuvant, and (4) the progresses in the design of HIV vaccine candidates able to induce broadly neutralizing antibodies.
Mots-clé
HIV vaccine, cationic polymer, formulation, technology transfer, vaccine adjuvant
Pubmed
Web of science
Création de la notice
13/01/2014 14:58
Dernière modification de la notice
20/08/2019 15:17
Données d'usage